Search results
Resistant Hypertension: An Overview
Author(s):
Giacomo Buso
,
Claudia Agabiti-Rosei
,
Matteo Lemoli
,
et al
Added:
1 year ago
Review Article
Author(s):
Harriette Van Spall
,
Luke Laffin
Added:
11 months ago
ACC 25 - ADVANCE-HTN shows lorundrostat, an aldosterone synthase inhibitor, effectively lowered 24-hour blood pressure in patients with uncontrolled and true resistant hypertension.Late-breaker discussion host, Dr Harriette Van Spall (McMaster University, Hamilton, CA) is joined by Dr Luke Laffin (Cleveland Clinic, Cleveland, OH, US) to discuss the key findings from the ADVANCE-HTN trial…
View more
Author(s):
Maria Lorenza Muiesan
,
Matteo Lemoli
Added:
4 months ago
Author(s):
Thomas Weber
,
Erika SW Jones
,
Bryan Williams
Added:
1 year ago
The long term clinical implications of uncontrolled hypertension are well documented, but almost half of those with hypertension remain inadequately treated. In this symposium, our panel of three leading hypertension experts, Prof Thomas Weber (Klinikum Wels-Grieskirchen, Wels, AT), Prof Bryan Williams (University College London, London, UK) and Prof Erika Jones (University of Cape Town, Cape…
View more
Recent Advances in Pulmonary Hypertension
Author(s):
Akshyaya Pradhan
,
Richa Tyagi
,
Prachi Sharma
,
et al
Added:
1 year ago
Review Article
Author(s):
Yassir Javaid, Michel Burnier, Mariya Tokmakova ,et al
Start date:
Jun 25, 2025
Join an expert panel of internationally recognised cardiovascular specialists for a CME-accredited* webinar on the latest strategies in hypertension management for patients with cardiovascular disease. Chaired by Dr Yassir Javaid (Imperial College Healthcare NHS Trust, London, UK), with Prof Michel Burnier (University Hospital of Lausanne, Lausanne, CH) Prof Mariya Tokmakova (Medical University…
View more
Cracking the Code of Uncontrolled Hypertension
Video Series
Author(s):
Rhian Touyz
Added:
1 year ago
ESC Congress 2024 — Dr Rhian Touyz (McGill University Health Center, CA) joins us to discuss key highlights from the ESC 2024 guidelines for the management of elevated blood pressure and hypertension.The new guidelines introduce a new systolic blood pressure treatment target range of 120-129 mmHg, placing emphasis on an intensive target treatment as the first step in patient management - only…
View more
Author(s):
Gerhard Hindricks
,
Faizel Osman
,
Keitaro Senoo
,
et al
Added:
2 years ago
This video series page covers content associated with Atrial Fibrillation.AFib is associated with a 5x greater risk of stroke, however with effective treatment, the risk of stroke can be reduced.¹ The lifetime risk for AFib is 1 in 3 individuals² and it often occurs with hypertension. Early detection is key, to allow for prompt and satisfactory disease management to not only control symptoms but…
View more